Evidence map›Paper›PMID 10053007›Full record

ArticleAmerican journal of human genetics1999

Cyclic ichthyosis with epidermolytic hyperkeratosis: A phenotype conferred by mutations in the 2B domain of keratin K1.

V P Sybert, J S Francis, L D Corden, L T Smith, M Weaver, K Stephens, W H McLean

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Case Report: Uncommon Association ofFrontiers in genetics · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Ichthyosis bullosa of Siemens.Journal of dermatological case reports · 2012
    Article
  10. Keratin gene mutations in disorders of human skin and its appendages.Archives of biochemistry and biophysics · 2011
    Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

V P SybertDepartments of Pediatrics, University of Washington School of Medicine, Children's Hospital and Medical Center, Division of Dermatology, CH-25, 4800 Sand Point Way NE, P.O. Box 5371, Seattle, WA 98105, USA flk01@u.washington.edu Julie S.
J S Francis
L D Corden
L T Smith
M Weaver
K Stephens
W H McLean
University of Washington · USSeattle Children's Hospital · USNinewells Hospital · GBUniversity of Dundee · GB

Funding

STRUCTURAL PROTEINS IN DISORDERS OF KERATINIZATIONP01AR021557 · NIAMS · UNIVERSITY OF WASHINGTON · PI STEPHENS, KAREN G · 1986 to 2001
$2.8M
NIADDK NIH HHS AM 62272NIAMS NIH HHS P01-AR21557
6 · The paper itself

Abstract

Bullous congenital ichthyosiform erythroderma (BCIE) is characterized by blistering and erythroderma in infancy and by erythroderma and ichthyosis thereafter. Epidermolytic hyperkeratosis is a hallmark feature of light and electron microscopy. Here we report on four individuals from two families with a unique clinical disorder with histological findings of epidermolytic hyperkeratosis. Manifesting erythema and superficial erosions at birth, which improved during the first few months of life, affected individuals later developed palmoplantar hyperkeratosis with patchy erythema and scale elsewhere on the body. Three affected individuals exhibit dramatic episodic flares of annular, polycyclic erythematous plaques with scale, which coalesce to involve most of the body surface. The flares last weeks to months. In the interim periods the skin may be normal, except for palmoplantar hyperkeratosis. Abnormal keratin-filament aggregates were observed in suprabasal keratinocytes from both probands, suggesting that the causative mutation might reside in keratin K1 or keratin K10. In one proband, sequencing of K1 revealed a heterozygous mutation, 1436T-->C, predicting a change of isoleucine to threonine in the highly conserved helix-termination motif. In the second family, a heterozygous mutation, 1435A-->T, was found in K1, predicting an isoleucine-to-phenylalanine substitution in the same codon. Both mutations were excluded in both a control population and all unaffected family members tested. These findings reveal that a clinical phenotype distinct from classic BCIE but with similar histology can result from K1 mutations and that mutations at this codon give rise to a clinically unique condition.

Indexed as

DNA Mutational AnalysisFluorescent Antibody TechniqueHumansHyperkeratosis, EpidermolyticKeratinsMaleMutation, MissensePedigreePhenotypePoint MutationSkinKeratins

Identifiers

PMID10053007
PMCPMC1377790
OpenAlexW2042926418

What OpenQuestion holds

Texttitle and abstract
measurements read1
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.